CIDRAP

The World Health Organization (WHO) today recommended the use of anti-inflammatory monoclonal antibodies—tocilizumab and sarilumab—alongside corticosteroids for treating patients who have severe or critical COVID-19 infections.

In other global developments, some countries including Indonesia, Vietnam, and Bangladesh, reported new record daily highs for infections, as COVID-19 cases continued to rise in parts of Europe.

READ FULL ARTICLE HERE > https://www.cidrap.umn.edu/news-perspective/2021/07/who-advises-2-monoclonal-antibodies-severe-covid

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *